Details for New Drug Application (NDA): 018197
✉ Email this page to a colleague
NDA 018197 describes RUFEN, which is a drug marketed by Basf and is included in one NDA. Additional details are available on the RUFEN profile page.
The generic ingredient in RUFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in RUFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Medical Subject Heading (MeSH) Categories for 018197
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
| Approval Date: | Mar 5, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
